Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHAHLA BARI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1487063525
CMS profile
1060217
Location
TAMPA, FL

General Payments · PY2020–2024

$10,635.07

  • Reported across 15 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,575.08

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $10,128.59 10
Telix Pharmaceuticals $148.58 1
Exelixis Inc. $136.78 1
PFIZER INC. $135.00 1
EISAI INC. $26.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $59.99 1
PY2024 $10,575.08 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Eisai Inc. $26.13 06/02/2024 Food and Beverage Undisputed 01/23/2026 1110780740 CMS
Exelixis Inc. $136.78 01/26/2024 Food and Beverage Undisputed 01/23/2026 1138565568 CMS
Merck Sharp & Dohme LLC $74.23 04/23/2024 Food and Beverage Undisputed 01/23/2026 1141870145 CMS
Merck Sharp & Dohme LLC $521.09 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1141704980 CMS
Merck Sharp & Dohme LLC $288.59 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1141705000 CMS
Merck Sharp & Dohme LLC $354.40 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1141705004 CMS
Merck Sharp & Dohme LLC $71.56 08/15/2024 Food and Beverage Undisputed 01/23/2026 1141705006 CMS
Merck Sharp & Dohme LLC $103.72 08/22/2024 Food and Beverage Undisputed 01/23/2026 1141705170 CMS
Merck Sharp & Dohme LLC $4,270.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141704982 CMS
Merck Sharp & Dohme LLC $150.00 09/11/2024 Travel and Lodging Undisputed 01/23/2026 1141871029 CMS
Merck Sharp & Dohme LLC $4,270.00 09/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141704984 CMS
Merck Sharp & Dohme LLC $25.00 09/25/2024 Travel and Lodging Undisputed 01/23/2026 1141705002 CMS
PFIZER INC. $135.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1131201325 CMS
Telix Pharmaceuticals $148.58 01/25/2024 Food and Beverage Undisputed 01/23/2026 1081981734 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.